MLLT3 and acute myeloid leukemia: In the human acute myeloid leukemia (AML) induced by the MLL-AF9 oncogene (MLL-AF9) mouse model, the abrogation of LSD1 resulted in a heightened rate of apoptosis and impaired leukemogenicity [45].